Union Strong, a Beijing-based firm that uses AI and other technology to treat cerebrovascular diseases, has secured “tens of millions of US dollars” in a Series C round led by Sequoia Capital China, the investee announced on Tuesday.
Returning investors who joined the round were BioTrack Capital, YuanBio Venture Capital and Sunland Fund, and Greenwaters Fund.
BioTrack Capital along with YuanBio Venture Capital, Lenovo Capital, and other investors, had together infused a similar-sized sum in Union Strong’s Series B+ round in February this year.
Investment banks CEC Capital and Probing Capital served as joint financial advisors for the deal.
Union Strong’s cloud computing system is used by hundreds of hospitals that help manage patients’ database, covering screening, diagnosis, and surgery.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on September 14, 2021.
|Startup||Headquarter||Investment Size (USD)||Investment Stage||Lead Investor(s)||Other Investor(s)||Verticals|
|DeepRoute.ai||Shenzhen||300 million||B||Alibaba Group||Jeneraion Capital, Fosun RZ Capital, Yunqi Partners, Glory Ventures||Autonomous Driving|
|XINYI Information Technology||Shanghai||77.5 million||B||CMB International, CICC Alpha||China Merchants Capital, Ningbo Water Meter, FreesFund, Chendao Capital, Huarui Investment||Internet of Things|
|Alebund Pharmaceuticals||Shanghai||54.50 million||B+||3H Health Investment||Morningside Ventures, Loyal Valley Capital, YuanBio Venture Capital, Octagon Capital, Verition Fund Management, HT Capital, Lilly Asia Ventures (LAV), Quan Capital, 3E Bioventures Capital, Sherpa Healthcare Partners||Biotech|
|Union Strong||Beijing||* 15 million||C||Sequoia Capital China||BioTrack Capital, Greenwaters Fund, YuanBio Venture Capital, Sunland Fund||HealthTech|
|Zhipu.AI||Beijing||15 million||A||-||Fortune Capital, TH Capital, J Ventures, Turing AI Institute of Nanjing, Beijing Dafan Technology, Tongzhi Investment, Zaozhuang Tongzhi, Rongpin Investment, Caizhi Chuangying, Luster||AI and Machine Learning|
|OncoCare||Suzhou||15 million||A+||Oriza Seed||Addor Capital||Biotech|
|Beijing Lingkong Space Technology||Beijing||15 million||A+||Silkroad Goldenbridge Capital Management||Skychee Ventures||Infrastructure|
|Scent Library||Beijing||* 10 million||B||-||PUIG||N/A|
|RichCreator||Nanjing||*1.5 million||C||-||Addor Capital||Infrastructure|
|Shenzhen Adaps Photonics Technology||Shenzhen||*1.5 million||B1||Gaorong Capital||OPPO, Kinzon Capital, ZhenFund, Shenzhen Oufei Investment Holdings||3D Printing|
|Greenstone Software||Beijing||*1.5 million||A||Intron Group||Zhongguancun Qianqian Fund||Autonomous Driving|
|Yololand||Shanghai||* 1 million||Angel||-||IDG Capital||N/A|
∗ indicates that the company did not provide the specific size of the deal but only a range. So, we adopt the smallest number in the range, which is “6.5 million yuan ($1 million)” in the given example.